Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation

BACKGROUND: Despite recent progress in molecular-targeted therapies, breast cancer remains the primary leading cause of cancer related death among women worldwide. Breast cancer stem cells (BCSCs) are believed to be responsible for therapy resistance and cancer recurrence. We recently demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Syahrani, Resda A, Yunita, Elvira, Wanandi, Septelia I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779466/
https://www.ncbi.nlm.nih.gov/pubmed/32986362
http://dx.doi.org/10.31557/APJCP.2020.21.9.2631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779466/
https://www.ncbi.nlm.nih.gov/pubmed/32986362
http://dx.doi.org/10.31557/APJCP.2020.21.9.2631

Ejemplares similares